PARATAXIS KOREA, INC.
288330KOSDAQOther scientific and technical services
PARATAXIS KOREA, INC. (288330, KOSDAQ) reported KRW 0bn revenue in 2025.
Reported financials
Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.
| Year | Revenue | Operating profit | Net profit | Assets | Equity | Basis |
|---|---|---|---|---|---|---|
| 2021 | 2 | — | -26 | 47 | 43 | Consolidated |
| 2022 | 3 | — | -42 | 61 | 52 | Consolidated |
| 2023 | 0 | — | -42 | 33 | 20 | Consolidated |
| 2024 | 0 | — | -20 | 33 | 28 | Consolidated |
| 2025 | 0 | — | -32 | 71 | 44 | Consolidated |
Ratios, year by year
Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.
| Year | Operating margin | Net margin | Equity / assets | Return on equity |
|---|---|---|---|---|
| 2021 | — | -1,365.7% | 92.3% | -61% |
| 2022 | — | -1,379.1% | 84.4% | -80.4% |
| 2023 | — | -42,455.3% | 60.3% | -215.3% |
| 2024 | — | -915,165.8% | 82.3% | -72.3% |
| 2025 | — | -358,217.4% | 61.8% | -73.6% |
Revenue moved -99.5% between 2021 and 2025.
Net profit was negative in the 5 most recent consecutive years on file. Counted from the 5 years in which the company filed a net-profit line — a year with no filing is skipped, not read as a loss.
These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.
Market size
| Market capitalisation | KRW 44bn |
|---|---|
| Close price | KRW 416 |
| Listed shares | 106,080,948 |
| Price as of | 20260909 |
Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.
When it was founded
The incorporation date on the company's registration record, as filed with Korea's Financial Supervisory Service. This is when the company was legally formed — not when it first listed, and not when the business it grew out of began trading.
| Incorporated |
|---|
Who runs it
Registered representative directors — in Korea this is the office a CEO holds. Filed with the Financial Supervisory Service (DART). A Korean company can register more than one, and the title beside each name is the rank they carry inside the company.
| Name | Title | Board seat | Years in post |
|---|---|---|---|
| Andrew Kim | Representative Director (CEO) | Inside director | 6 months |
Some Roman spellings here are not ours — the company filed them itself, either beside the Korean name or in place of one. Those are the spellings the company uses.
Workforce — a side measure, not the main one
| Employees (2025) | 16 |
|---|---|
| Women | 9 (56.3%) |
| Average tenure | 4 years |
| Annual pay, men | KRW 82,152,000 |
| Annual pay, women | KRW 68,626,000 |
| Pay ratio, women to men | 83.5% |
Other companies in Other scientific and technical services
18 listed companies file under this classification. Showing 12.
- Psomagen, Inc.
- P&K Skin Research Center Co.,Ltd.
- Quality Reliability Technology Inc.
- NGeneBio Co., Ltd.
- SIGONG TECH Co.,Ltd.
- Nepes Ark Corporation
- SLSBio(Specialty Lab Solution Bio) Co., Ltd
- Macrogen, Inc.
- Solumix co,.Ltd.
- ITEK, Inc.
- WOOJIN Ntec Inc.
- Gridwiz Co.,Ltd
See the whole Other scientific and technical services list →